See more : M&A Capital Partners Co.,Ltd. (6080.T) Income Statement Analysis – Financial Results
Complete financial analysis of Boryung Corporation (003850.KS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Boryung Corporation, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Vista Outdoor Inc. (VSTO) Income Statement Analysis – Financial Results
- NTT System S.A. (NTT.WA) Income Statement Analysis – Financial Results
- Solvay SA (SVYSF) Income Statement Analysis – Financial Results
- Ignyte Acquisition Corp. (IGNYU) Income Statement Analysis – Financial Results
- The Sandur Manganese & Iron Ores Limited (SANDUMA.NS) Income Statement Analysis – Financial Results
Boryung Corporation (003850.KS)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.boryung.co.kr
About Boryung Corporation
Boryung Corporation produces and sells pharmaceutical products in South Korea. The company offers cardiovascular products, anticancer products, gastrointestinal products, and API's. It also exports its products to approximately 50 countries on 6 continents, including Japan, China, the Southeast Asia, the Middle East, Europe, South America, and Africa. The company was formerly known as Boryung Pharmaceutical Co., Ltd. and changed its name to Boryung Corporation in March 2022. Boryung Corporation was founded in 1957 and is based in Seoul, South Korea.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 859.63B | 760.48B | 627.28B | 561.87B | 524.27B | 460.40B | 422.72B | 409.14B | 401.35B | 359.49B | 327.28B | 312.08B | 308.01B | 300.96B | 267.84B | 223.26B | 197.50B |
| Cost of Revenue | 506.20B | 453.29B | 362.34B | 330.42B | 301.27B | 271.79B | 254.90B | 232.53B | 232.36B | 199.32B | 186.35B | 185.73B | 181.64B | 179.92B | 159.24B | 128.07B | 98.22B |
| Gross Profit | 353.43B | 307.19B | 264.94B | 231.44B | 222.99B | 188.61B | 167.82B | 176.61B | 168.99B | 160.17B | 140.92B | 126.34B | 126.37B | 121.04B | 108.60B | 95.19B | 99.28B |
| Gross Profit Ratio | 41.11% | 40.39% | 42.24% | 41.19% | 42.53% | 40.97% | 39.70% | 43.17% | 42.10% | 44.55% | 43.06% | 40.48% | 41.03% | 40.22% | 40.55% | 42.64% | 50.27% |
| Research & Development | 47.29B | 41.71B | 39.15B | 35.51B | 37.86B | 34.43B | 32.28B | 28.96B | 29.72B | 25.75B | 24.50B | 28.23B | 25.56B | 17.54B | 17.52B | 14.61B | 14.10B |
| General & Administrative | 19.21B | 17.85B | 21.87B | 17.97B | 22.15B | 35.92B | 37.30B | 37.58B | 33.54B | 35.88B | 31.59B | 30.80B | 29.74B | 17.58B | 15.93B | 12.35B | 11.87B |
| Selling & Marketing | 72.84B | 74.17B | 67.59B | 56.91B | 55.17B | 44.96B | 55.89B | 41.49B | 37.08B | 33.57B | 29.07B | 27.48B | 29.93B | 29.05B | 28.12B | 23.42B | 23.93B |
| SG&A | 92.06B | 92.02B | 89.46B | 74.89B | 77.32B | 80.87B | 93.19B | 79.07B | 70.62B | 69.45B | 60.65B | 58.28B | 59.68B | 46.64B | 44.05B | 35.77B | 35.79B |
| Other Expenses | 145.82B | 116.86B | 94.88B | 81.06B | 68.75B | 1.40B | 74.36B | -78.36M | 792.08M | 5.07B | 2.86B | 4.22B | 0.00 | 946.35M | -53.37M | 195.87M | 1.98B |
| Operating Expenses | 285.16B | 250.58B | 223.49B | 191.46B | 183.93B | 163.66B | 166.80B | 154.59B | 141.44B | 135.73B | 121.79B | 122.97B | 116.65B | 103.76B | 98.42B | 87.36B | 85.55B |
| Cost & Expenses | 791.92B | 703.87B | 585.83B | 521.88B | 485.20B | 435.45B | 421.70B | 387.13B | 373.80B | 335.06B | 308.14B | 308.70B | 298.29B | 283.69B | 257.67B | 215.42B | 183.78B |
| Interest Income | 871.77M | 4.52B | 1.40B | 482.14M | 16.22M | 165.02M | 1.36B | 164.42M | 26.23M | 12.35M | 102.96M | 160.27M | 3.28M | 329.91M | 329.54M | 591.36M | 588.94M |
| Interest Expense | 9.55B | 6.13B | 4.48B | 3.34B | 62.13M | 96.55M | 361.47M | 963.41M | 1.18B | 1.15B | 1.67B | 2.44B | 2.37B | 1.01B | 415.35M | 534.67M | 1.11B |
| Depreciation & Amortization | 44.39B | 36.56B | 32.07B | 27.57B | 17.43B | 16.14B | 16.26B | 15.32B | 12.78B | 11.13B | 10.55B | 10.49B | 9.32B | 7.83B | 7.78B | 6.61B | 6.75B |
| EBITDA | 110.24B | 105.72B | 81.82B | 67.53B | 62.70B | 45.36B | 93.62B | 43.98B | 41.77B | 40.89B | 32.53B | 18.28B | 19.18B | 27.17B | 17.45B | 15.70B | 22.97B |
| EBITDA Ratio | 12.82% | 14.12% | 16.19% | 11.95% | 11.70% | 8.59% | 22.20% | 9.36% | 10.49% | 11.37% | 9.93% | 5.86% | 6.23% | 8.97% | 6.53% | 6.66% | 11.65% |
| Operating Income | 68.27B | 56.60B | 69.46B | 39.99B | 39.06B | 24.96B | 1.02B | 22.01B | 27.55B | 24.44B | 19.14B | 3.37B | 9.78B | 17.27B | 10.18B | 7.84B | 13.73B |
| Operating Income Ratio | 7.94% | 7.44% | 11.07% | 7.12% | 7.45% | 5.42% | 0.24% | 5.38% | 6.86% | 6.80% | 5.85% | 1.08% | 3.18% | 5.74% | 3.80% | 3.51% | 6.95% |
| Total Other Income/Expenses | -11.96B | 2.27B | -24.19B | -3.94B | -3.12B | -5.41B | 75.36B | -4.40B | 265.13M | 4.18B | 1.18B | 1.98B | -2.29B | 1.06B | -927.79M | 720.28M | 1.37B |
| Income Before Tax | 56.31B | 58.87B | 70.72B | 36.04B | 42.47B | 26.57B | 76.38B | 21.46B | 27.82B | 28.61B | 20.31B | 5.35B | 7.49B | 18.33B | 9.25B | 8.56B | 15.10B |
| Income Before Tax Ratio | 6.55% | 7.74% | 11.27% | 6.42% | 8.10% | 5.77% | 18.07% | 5.25% | 6.93% | 7.96% | 6.21% | 1.72% | 2.43% | 6.09% | 3.45% | 3.83% | 7.64% |
| Income Tax Expense | 16.09B | 16.93B | 27.60B | 9.18B | 10.25B | 6.26B | 19.90B | 15.85B | 7.52B | 7.02B | 6.19B | -4.05B | 1.31B | 4.69B | 4.07B | 3.35B | 6.68B |
| Net Income | 40.20B | 41.89B | 43.04B | 26.86B | 32.22B | 20.31B | 56.70B | 5.61B | 20.30B | 21.59B | 14.13B | 9.40B | 6.18B | 13.65B | 5.18B | 5.21B | 8.42B |
| Net Income Ratio | 4.68% | 5.51% | 6.86% | 4.78% | 6.15% | 4.41% | 13.41% | 1.37% | 5.06% | 6.01% | 4.32% | 3.01% | 2.01% | 4.54% | 1.93% | 2.33% | 4.26% |
| EPS | 610.38 | 635.91 | 688.72 | 452.86 | 569.48 | 358.87 | 988.65 | 103.09 | 334.64 | 355.71 | 232.12 | 153.74 | 110.60 | 231.68 | 87.96 | 94.76 | 156.30 |
| EPS Diluted | 609.77 | 633.55 | 682.93 | 452.01 | 569.48 | 358.87 | 988.65 | 103.09 | 334.64 | 355.71 | 232.12 | 153.74 | 110.60 | 231.68 | 87.96 | 94.76 | 156.30 |
| Weighted Avg Shares Out | 65.87M | 65.88M | 62.50M | 59.30M | 56.58M | 56.59M | 57.35M | 54.46M | 60.67M | 60.70M | 60.86M | 61.15M | 55.84M | 58.91M | 58.91M | 54.93M | 53.86M |
| Weighted Avg Shares Out (Dil) | 65.93M | 66.13M | 63.03M | 59.41M | 56.58M | 56.59M | 57.35M | 54.46M | 60.67M | 60.70M | 60.86M | 61.15M | 55.84M | 58.91M | 58.91M | 54.93M | 53.86M |
Source: https://incomestatements.info
Category: Stock Reports